Annual SG&A:
$31.87M+$8.41M(+35.88%)Summary
- As of today, EWTX annual SG&A is $31.87 million, with the most recent change of +$8.41 million (+35.88%) on December 31, 2024.
- During the last 3 years, EWTX annual SG&A has risen by +$20.84 million (+189.01%).
- EWTX annual SG&A is now at all-time high.
Performance
EWTX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$9.05M-$150.00K(-1.63%)Summary
- As of today, EWTX quarterly SG&A is $9.05 million, with the most recent change of -$150.00 thousand (-1.63%) on June 30, 2025.
- Over the past year, EWTX quarterly SG&A has increased by +$1.63 million (+21.88%).
- EWTX quarterly SG&A is now -1.63% below its all-time high of $9.20 million, reached on March 31, 2025.
Performance
EWTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.59B-$150.70M(-10.45%)Summary
- As of today, EWTX TTM SG&A is -$1.59 billion, with the most recent change of -$150.70 million (-10.45%) on June 30, 2025.
- Over the past year, EWTX TTM SG&A has dropped by -$1.62 billion (-6147.68%).
- EWTX TTM SG&A is now -4563.23% below its all-time high of -$34.15 million.
Performance
EWTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
EWTX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +35.9% | +21.9% | -6147.7% |
| 3Y3 Years | +189.0% | +121.4% | -10000.0% |
| 5Y5 Years | +2351.2% | +2746.5% | -10000.0% |
EWTX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +189.0% | -1.6% | +107.2% | -296.6% | at low |
| 5Y | 5-Year | at high | +2351.2% | -1.6% | +2746.5% | -4563.2% | at low |
| All-Time | All-Time | at high | +2351.2% | -1.6% | +3121.3% | -4563.2% | at low |
EWTX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $9.05M(-1.6%) | $35.63M(+4.8%) |
| Mar 2025 | - | $9.20M(+0.3%) | $34.01M(+6.7%) |
| Dec 2024 | $31.87M(+35.9%) | $9.17M(+11.7%) | $31.87M(+10.4%) |
| Sep 2024 | - | $8.21M(+10.5%) | $28.87M(+9.7%) |
| Jun 2024 | - | $7.43M(+5.2%) | $26.33M(+6.7%) |
| Mar 2024 | - | $7.06M(+14.3%) | $24.68M(+5.2%) |
| Dec 2023 | $23.45M(+33.1%) | $6.18M(+9.0%) | $23.45M(+3.1%) |
| Sep 2023 | - | $5.67M(-2.0%) | $22.74M(+6.1%) |
| Jun 2023 | - | $5.78M(-0.8%) | $21.44M(+8.6%) |
| Mar 2023 | - | $5.83M(+6.6%) | $19.75M(+12.1%) |
| Dec 2022 | $17.63M | $5.47M(+25.2%) | $17.63M(+10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $4.37M(+6.8%) | $15.89M(+8.0%) |
| Jun 2022 | - | $4.09M(+10.5%) | $14.72M(+11.3%) |
| Mar 2022 | - | $3.70M(-0.9%) | $13.23M(+20.0%) |
| Dec 2021 | $11.03M(+399.1%) | $3.73M(+16.8%) | $11.03M(+29.8%) |
| Sep 2021 | - | $3.20M(+23.0%) | $8.50M(+60.3%) |
| Jun 2021 | - | $2.60M(+73.6%) | $5.30M(+75.5%) |
| Mar 2021 | - | $1.50M(+24.2%) | $3.02M(+67.4%) |
| Dec 2020 | $2.21M(+69.9%) | $1.21M(+278.9%) | $1.80M(+201.2%) |
| Jun 2020 | - | $318.00K(+13.2%) | $599.00K(+113.2%) |
| Mar 2020 | - | $281.00K | $281.00K |
| Dec 2019 | $1.30M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual SG&A year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM SG&A year-on-year change?
What is Edgewise Therapeutics, Inc. annual SG&A?
The current annual SG&A of EWTX is $31.87M
What is the all-time high annual SG&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual SG&A is $31.87M
What is Edgewise Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, EWTX annual SG&A has changed by +$8.41M (+35.88%)
What is Edgewise Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of EWTX is $9.05M
What is the all-time high quarterly SG&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly SG&A is $9.20M
What is Edgewise Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, EWTX quarterly SG&A has changed by +$1.63M (+21.88%)
What is Edgewise Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of EWTX is -$1.59B
What is the all-time high TTM SG&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM SG&A is -$34.15M
What is Edgewise Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, EWTX TTM SG&A has changed by -$1.62B (-6147.68%)